Deep Medicine Acquisition (Deep Medicine Acquisition) EV-to-EBIT : -8.23 (As of May. 28, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Deep Medicine Acquisition EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Deep Medicine Acquisition's Enterprise Value is $15.74 Mil. Deep Medicine Acquisition's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.91 Mil. Therefore, Deep Medicine Acquisition's EV-to-EBIT for today is -8.23.

The historical rank and industry rank for Deep Medicine Acquisition's EV-to-EBIT or its related term are showing as below:

DMAQ' s EV-to-EBIT Range Over the Past 10 Years
Min: -1716.07 Med: 0 Max: 0
Current: -8.23

DMAQ's EV-to-EBIT is not ranked
in the Diversified Financial Services industry.
Industry Median: 8.55 vs DMAQ: -8.23

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Deep Medicine Acquisition's Enterprise Value for the quarter that ended in Sep. 2023 was $52.78 Mil. Deep Medicine Acquisition's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.91 Mil. Deep Medicine Acquisition's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -3.62%.

Deep Medicine Acquisition EV-to-EBIT Historical Data

The historical data trend for Deep Medicine Acquisition's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deep Medicine Acquisition EV-to-EBIT Chart

Deep Medicine Acquisition Annual Data

Trend

Mar21

Mar22

Mar23

EV-to-EBIT

-396.68

-23.19

Deep Medicine Acquisition Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EV-to-EBIT	Get a 7-Day Free Trial							-126.99	-31.52	-23.19	-23.79	-27.61

Competitive Comparison of Deep Medicine Acquisition's EV-to-EBIT

For the Shell Companies subindustry, Deep Medicine Acquisition's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deep Medicine Acquisition's EV-to-EBIT Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Deep Medicine Acquisition's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Deep Medicine Acquisition's EV-to-EBIT falls into.

Deep Medicine Acquisition EV-to-EBIT Calculation

Deep Medicine Acquisition's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	15.738	/	-1.912
	=	-8.23

Deep Medicine Acquisition's current Enterprise Value is $15.74 Mil.
Deep Medicine Acquisition's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.91 Mil.

Deep Medicine Acquisition (NAS:DMAQ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Deep Medicine Acquisition's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 )	=	EBIT	/	Enterprise Value (Q: Sep. 2023 )
	=	-1.912	/	52.781132
	=	-3.62 %

Deep Medicine Acquisition's Enterprise Value for the quarter that ended in Sep. 2023 was $52.78 Mil.
Deep Medicine Acquisition's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.91 Mil.

Deep Medicine Acquisition EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Deep Medicine Acquisition's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Deep Medicine Acquisition (Deep Medicine Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

595 Madison Avenue, 12th Floor, New York, NY, USA, 10017

Website

Deep Medicine Acquisition Corp is a blank check company.

Executives

John Chiang	director	3538 TORRANCE BLVD., UNIT 177, TORRANCE CA 90503
Bryant Fong	director	2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Humphrey P Polanen	director, officer: Chief Executive Officer	C/O HERITAGE COMMERCE CORP, 150 ALMADEN BLVD, SAN JOSE CA 95113
Weixuan Luo	officer: Chief Financial Officer	40 WALL STREET, 29TH FLOOR, NEW YORK NY 10005
Marc Hamer	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Bright Vision Sponsor Llc	10 percent owner	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Ronald M. Razmi	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Hongliang Ren	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Wanlei Miao	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Tina Spires	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017